Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Aggressive therapy and combination therapy in severe hyperlipidemia].

K M Kostner1

  • 1Klinischen Abteilung für Kardiologie, Universitätsklinik für Innere Medizin II, Wien. kkostner@pop3.kard.akh.wien.ac.at

Wiener Medizinische Wochenschrift (1946)
|July 17, 1999
PubMed
Summary

Severe hyperlipidemia is effectively managed with LDL-apheresis for familial hypercholesterolemia and lipid-lowering drugs for other types. Combination therapies, including statins like atorvastatin and simvastatin, significantly reduce LDL-cholesterol levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of fat mobilizing genes in human epicardial adipose tissue.

Atherosclerosis·2011
Same author

Therapy of hyper-Lp(a).

Handbook of experimental pharmacology·2006
Same author

Does lipoprotein(a) predict risk in type 2 diabetes?

European journal of clinical investigation·2006
Same author

Plasma delipidation process induces rapid regression of atherosclerosis and mobilisation of adipose tissue.

Journal of clinical apheresis·2005
Same author

Effects of simvastatin on blood lipids, vitamin E, coenzyme Q10 levels and left ventricular function in humans.

European journal of clinical investigation·2005
Same author

Activation of the complement system: a crucial link between inflammation and atherosclerosis?

European journal of clinical investigation·2004

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Pharmacology

Background:

  • Severe hyperlipidemia, particularly familial hypercholesterolemia, poses significant health risks.
  • Current therapeutic guidelines emphasize aggressive lipid-lowering strategies.

Purpose of the Study:

  • To discuss various therapeutic options for severe hyperlipidemia.
  • To highlight the efficacy of LDL-apheresis and lipid-lowering drugs.

Main Methods:

  • Review of current therapeutic tools for hyperlipidemia.
  • Discussion of combination therapies involving statins.

Main Results:

  • LDL-apheresis is the most effective treatment for homozygous familial hypercholesterolemia.
  • Statins like atorvastatin and simvastatin can reduce LDL-cholesterol by up to 60%.

Related Experiment Videos

  • Combination therapy with LDL-apheresis and statins can achieve up to 80% LDL-cholesterol reduction.

    • Conclusions:

    • Effective management of severe hyperlipidemia is achievable with current therapies.
    • Aggressive lipid-lowering strategies are crucial and supported by scientific society recommendations.